Aridis Pharmaceuticals Statistics Share Statistics Aridis Pharmaceuticals has 44.57M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 44.57M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) 0% Shares Floating 36.9M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 2M, so undefined% of the outstanding
shares have been sold short.
Short Interest 2M Short % of Shares Out n/a Short % of Float 5.37% Short Ratio (days to cover) 0.22
Valuation Ratios The PE ratio is -0.72 and the forward
PE ratio is null.
Aridis Pharmaceuticals's PEG ratio is
0.01.
PE Ratio -0.72 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio -0.91 P/FCF Ratio -0.76 PEG Ratio 0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Aridis Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.32,
with a Debt / Equity ratio of -0.25.
Current Ratio 0.32 Quick Ratio 0.32 Debt / Equity -0.25 Debt / EBITDA -0.21 Debt / FCF -0.21 Interest Coverage -79.35
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-831.05K Employee Count 37 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 378K Effective Tax Rate -1.24%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is -26.04, so Aridis Pharmaceuticals's
price volatility has been lower than the market average.
Beta -26.04 52-Week Price Change n/a 50-Day Moving Average 0 200-Day Moving Average 0.01 Relative Strength Index (RSI) 50.3 Average Volume (20 Days) n/a
Income Statement
Revenue n/a Gross Profit n/a Operating Income -29.99M Net Income -30.75M EBITDA -29.51M EBIT n/a Earnings Per Share (EPS) -1.64
Full Income Statement Balance Sheet The company has 4.88M in cash and 6.13M in
debt, giving a net cash position of -1.25M.
Cash & Cash Equivalents 4.88M Total Debt 6.13M Net Cash -1.25M Retained Earnings -195.67M Total Assets 6.53M Working Capital -13.37M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -29.13M
and capital expenditures -82K, giving a free cash flow of -29.21M.
Operating Cash Flow -29.13M Capital Expenditures -82K Free Cash Flow -29.21M FCF Per Share -1.56
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
